| |
| |
|
| Insider
Information: |
Davis George Eric |
| Relationship: |
EVP, Chief Legal Officer |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
56,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,977,195 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
56,157 |
|
|
| Total
Value |
$4,977,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Legal Officer |
2024-05-02 |
56,157 |
2007-02-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
223 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-05-16 |
4 |
OE |
$14.39 |
$16,491 |
D/D |
1,146 |
85,301 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-02 |
4 |
D |
$90.72 |
$134,991 |
D/D |
(1,488) |
83,813 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-05 |
4 |
S |
$91.04 |
$862,230 |
D/D |
(9,471) |
74,342 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-09 |
4 |
OE |
$21.51 |
$217,530 |
D/D |
9,239 |
83,581 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-23 |
4 |
OE |
$38.59 |
$379,880 |
D/D |
9,844 |
93,425 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-06-23 |
4 |
AS |
$96.60 |
$950,930 |
D/D |
(9,844) |
83,581 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2017-11-30 |
4 |
S |
$85.64 |
$102,767 |
D/D |
(1,200) |
82,942 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-02-01 |
4 |
OE |
$38.59 |
$1,157,700 |
D/D |
30,000 |
112,942 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-02-01 |
4 |
AS |
$90.66 |
$2,719,665 |
D/D |
(30,000) |
82,942 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
11,601 |
94,343 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
11,523 |
94,265 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-02 |
4 |
D |
$79.86 |
$165,390 |
D/D |
(2,071) |
92,194 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-05 |
4 |
AS |
$79.04 |
$166,379 |
D/D |
(2,105) |
90,089 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,120 |
98,452 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-15 |
4 |
D |
$83.57 |
$313,972 |
D/D |
(3,757) |
86,332 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-16 |
4 |
AS |
$83.88 |
$320,254 |
D/D |
(3,818) |
94,634 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-22 |
4 |
D |
$81.36 |
$268,081 |
D/D |
(3,295) |
91,339 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-22 |
4/A |
D |
$81.36 |
$269,139 |
D/D |
(3,308) |
91,326 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-03-23 |
4 |
AS |
$81.35 |
$272,523 |
D/D |
(3,350) |
87,989 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
88,364 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-06-04 |
4 |
D |
$92.07 |
$130,187 |
D/D |
(1,414) |
86,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-09-13 |
4 |
S |
$99.57 |
$1,194,840 |
D/D |
(12,000) |
74,950 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2018-09-14 |
4 |
S |
$99.45 |
$220,386 |
D/D |
(2,216) |
72,734 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-01 |
4 |
D |
$94.76 |
$79,598 |
D/D |
(840) |
83,747 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, General Counsel |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,853 |
84,587 |
0 |
- |
|
223 Records found
|
|
Page 3 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
